ChemicalBook >> journal list >> Nature Communications >>article
Nature Communications

Nature Communications

IF: 14.7
Download PDF

Cell-inspired dual-tandem catalytic nanoreactors drive targeted hearing protection

Published:28 August 2026 DOI: 10.1038/s41467-026-76994-3
Baoying Xu, Xinru Chen, Kaixuan Hu, Jijun Sun, Yuqi Huang, Wenjing Li, Wei Feng, Yujie Xie, Dehong Yu, Yu Chen

Abstract

Sensorineural hearing loss is driven by disruption of cochlear homeostasis, where dysregulated redox, ionic, and metabolic factors lead to hair cell degeneration and synaptic injury. Current strategies lack the capacity to restore the enzymatic clearance of reactive oxygen species or penetrate the blood-labyrinth barrier. Here, we report a cell-inspired dual-tandem catalytic nanoreactor (HSC@Se) integrating GPx-mimetic diselenide with superoxide dismutase and catalase to reconstruct the detoxification cascade. We show that the albumin scaffold stabilizes the nanoarchitecture and enables active blood-labyrinth barrier penetration of neutrophil-adhesive transport and megalin-mediated uptake, facilitating cochlear delivery to hair cells and spiral ganglion neurons. In noise-induced mouse models, we demonstrate that HSC@Se restores redox equilibrium, suppresses ferroptosis, normalizes iron handling, preserves hair-cell integrity, maintains ribbon synapses, and reduces auditory threshold shifts. We perform transcriptomics to reveal activation of antioxidative and metabolic repair pathways. This work presents cell-inspired nanoreactors that emulate natural antioxidant networks to rebalance cochlear redox homeostasis and drive hearing protection.

Substances (3)

Materials
Procduct Name CAS Molecular Formula Supplier Price
N-Hydroxysuccinimide 6066-82-6 C4H5NO3 1058 suppliers $4.00-$4605.50
CATALASE 9001-05-2 C9H10O3 480 suppliers $40.00-$1838.50
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide 1892-57-5 C8H17N3 392 suppliers $5.00-$2862.08

Similar articles

IF:3

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer

Saudi Pharmaceutical Journal Silky Bedi , Shah A. Khan ,etc Published: 1 September 2018
IF:2.2

Mitigating hemoglobin‐induced nephropathy: ApoHb‐hp protection of podocytes

Physiological Reports Daniela Lucas, Carlos Munoz,etc Published: 1 November 2024
IF:9.1

Multi-targeted prevention of cancer by sulforaphane

Cancer letters John D. Clarke , Roderick H. Dashwood ,etc Published: 8 October 2008